Apimeds Pharmaceuticals US APUS
NYSE APUS
$3.20 -0.21 (-6.14%)
As of: Oct 21, 2026 · 3:59 PM EDT

Apimeds Pharmaceuticals US (APUS) Prepaid Assets (2023 - 2026)

Updated

Apimeds Pharmaceuticals US (APUS) posted Prepaid Assets of $2.24 million for Q2 2026, up 38.5% from $1.61 million a year earlier.

Analysis

Apimeds Pharmaceuticals US (APUS) Prepaid Assets (2023 - 2026) Analysis & Trends

At the end of FY2025, Apimeds Pharmaceuticals US's Prepaid Assets came in at $2.3 million.

  • In prior years, Apimeds Pharmaceuticals US's Prepaid Assets was $9,602 in FY2024 (-17.2%) and $11,595 in FY2023.
  • Quarterly Prepaid Assets has run from a low of $9,562 in Q1 2025 to a high of $2.3 million in Q4 2025 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Apimeds Pharmaceuticals US 5.44 Mn -14.20 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.24 Mn
Dec 31, 2025 2.30 Mn
Sep 30, 2025 2.10 Mn
Jun 30, 2025 1.61 Mn
Mar 31, 2025 9,562.00
Dec 31, 2024 9,602.00
Dec 31, 2023 11,595.00
API Access

Apimeds Pharmaceuticals US Prepaid Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=prepaid-assets&ticker=APUS&period=max&api_key=YOUR_API_KEY